Olawumi Giwa

Olawumi Giwa
Olawumi Giwa

Ph.D. Student

Ph.D. Project Title: The experimental validation of gene-gene fusions as a diagnostic tool for the detection of Glioblastoma Multiforme (GBM)

Olawumi Giwa, a Doctoral student in the Cancer Genomics and Biocomputing of Complex diseases Laboratory. She obtained a Bachelor and Master’s degree in Biochemistry from the University of Port Harcourt and Ibadan, Nigeria.
Olawumi is currently validating chimaeras as diagnostic tools for detecting Glioblastoma Multiforme, using cell-free DNA from patient’s liquid biopsy. She will be utilizing techniques including Probe-based Polymerase Chain Reaction (qPCR), Next-generation sequencing, cloning, and the Sanger sequencing to achieve these goals. Her goal is to apply these techniques in the future to probe other forms of cancer signatures upon validation, novel drug targets and precision medicine for GBM patients to improve the patient’s prognostic outcomes.

Conference attended:

  • Presented a poster on 10th Annual Translational Research Day.  The Azrieli Faculty of Medicine, Bar-Ilan University. 1st July 2021.
  • Presented a poster in Tuller Lab conference 2021, Tel Aviv University

Publication from MFM lab:

  1. Rajesh Detroja, Alessandro Gorohovski, Olawumi Giwa, Gideon Baum and Milana FrenkelMorgenstern, “ChiTaH: A fast and accurate reference-based approach for identifying known chimeras, revealed as heterogeneity in bulk and single-cell high-throughput sequencing data.” (Under Review)